Sight Sciences, Inc.

Dec 01, 2020

Sight Sciences Announces Substantial Crossover Raise

Aug 10, 2020

Sight Sciences Announces First Patients Enrolled in ORION: A Prospective, Multicenter Clinical Trial of the OMNI Surgical System in Pseudophakic, Mild-to-Moderate Glaucoma Patients

May 18, 2020

Sight Sciences Announces Positive Clinical Results from Randomized, Controlled Trial of TearCare for the Treatment of Dry Eye Disease

May 07, 2020

Sight Sciences Introduces the Next-Generation OMNI® Surgical System for Microinvasive Glaucoma Surgery

Mar 30, 2020

Sight Sciences Announces Publication of Historical Review of Canal Surgery in the Glaucoma Issue of Current Opinion in Ophthalmology

Mar 18, 2020

Sight Sciences Announces $30 Million Financing Led by D1 Capital Partners

Mar 10, 2020

Sight Sciences Announces Publication of First-Ever Multicenter MIGS study in Childhood Glaucoma